Clinical trials in Cutaneous lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for cutaneous lymphoma patients.

If you would like to know how to access our trials please click here

 

 

Trial Name

 

Description

 

Click for more information (external page)

 

RESMAIN

 

Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.

Suitable for patients who have received treatment and their lymphoma is stable or in remission

 

 

 

SOLAR

 

Phase 2 study testing a targeted treatment called cobomarsen (also known as MRG-106) in people with a type of T-cell skin lymphoma (cutaneous T-cell lymphoma) called mycosis funcgoides

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

PORT

 

Phase 2 study testing the use of radiotherapy in addition to pembrolizumab for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

*Please note, we update this page fortnightly

With special thanks to the following: